Manipal Health Enterprises IPO 2026: GMP, Price Band, Dates, Review & Financial Analysis

The Manipal Health Enterprises IPO is one of the biggest healthcare IPOs of 2026, raising ₹9,275.22 crore through a book-built issue. The IPO will open for subscription from 29 July to 31 July 2026 and is scheduled to list on BSE and NSE on 5 August 2026.

The issue consists of a fresh issue worth ₹8,000 crore and an Offer for Sale (OFS) worth ₹1,275.22 crore. The company has fixed a price band of ₹560–₹590 per share, while the minimum investment for retail investors is ₹14,750 for one lot of 25 shares.

This article covers the Manipal Health Enterprises IPO details, GMP today, subscription status, business overview, financial performance, objectives, risks, listing date, and investment review.

Manipal Health Enterprises IPO Details

Manipal Health Enterprises IPO Timeline

Financial Performance

Key Financial Ratios

Objects of the IPO

The company plans to utilize the IPO proceeds for:
 

Manipal Health Enterprises IPO GMP Today

As of 24 July 2026, the Manipal Health Enterprises IPO GMP today stands at ₹28 per share.

The GMP has shown a positive trend over the last few days, indicating strong interest in the grey market. However, GMP is unofficial and should not be the sole basis for an investment decision.

Manipal Health Enterprises IPO Day-wise GMP Trend

Manipal Health Enterprises IPO Live Subscription Status

The IPO opens for bidding on 29 July 2026.

We'll update the live subscription figures as soon as bidding begins.

Manipal Health Enterprises IPO Day-wise Subscription Trend

What is current subscription data for Manipal Health Enterprises IPO ?

The current subscription data is updated in report by the total number of offering compare with total shares bid in each category for Manipal Health Enterprises IPO. Numbers are calculated from BSE, NSE data.

About Manipal Health Enterprises (Leadership & Business Model)

Founded as part of the Manipal Group by Dr. T. M. A. Pai, Manipal Health Enterprises Limited has grown into one of India's leading healthcare providers. The company operates a nationwide network of multi-specialty hospitals, clinics, and diagnostic centres offering advanced tertiary and quaternary healthcare services.

Its healthcare portfolio includes cardiology, oncology, neurology, orthopaedics, organ transplantation, emergency care, critical care, preventive healthcare, and advanced diagnostics. The company follows a patient-centric model supported by experienced doctors, modern medical infrastructure, and digital healthcare initiatives.

As of 30 September 2025, the company operated 38 hospitals (48 on a pro-forma basis), 17 clinics, and 10,761 licensed beds (12,367 on a pro-forma basis), making it one of India's largest private hospital networks. It has established a strong presence across metro as well as non-metro cities, with leadership positions in Bengaluru, Kolkata, and Pune.

The company continues expanding through acquisitions, partnerships, and capacity additions while focusing on improving operational efficiency and clinical excellence. Its diversified hospital network, strong brand recognition, and growing healthcare demand position Manipal Health Enterprises as a major player in India's organized healthcare sector.

Hospital Network & Infrastructure

• 38 operational hospitals (48 on pro-forma basis)
• 17 clinics across India
• 10,761 licensed beds (12,367 pro-forma)
• Presence across metro and non-metro markets
• Leadership positions in Bengaluru, Kolkata, and Pune
• Advanced medical technology and digital healthcare ecosystem

Competitive Strengths

• One of India's largest hospital chains by bed capacity
• Strong brand recognition in healthcare
• Leadership across major metropolitan markets
• Diversified presence across specialties
• High operational efficiency and profitability
• Continuous expansion through acquisitions and partnerships

Risks

• Healthcare regulations may impact profitability.
• High capital expenditure requirements.
• Integration risks from acquisitions.
• Dependence on skilled medical professionals.
• Increasing competition from large hospital chains.

Should You Invest in Manipal Health Enterprises IPO?

Manipal Health Enterprises is one of India's largest hospital operators with a strong brand, nationwide presence, diversified specialties, and consistent profitability. The IPO proceeds will strengthen the balance sheet and support strategic expansion through acquisitions.

The current GMP of ₹28 indicates positive grey market sentiment, although GMP should not be the only investment criterion. Investors should evaluate the company's valuation, financial performance, peer comparison, and long-term growth prospects before applying.

Invest Before Listing (UnlistedKraft)

If Manipal Health Enterprises shares become available in the unlisted market before listing, investors can check the latest share price, valuation, availability, and investment process on UnlistedKraft's dedicated unlisted shares platform.

Summary

The Manipal Health Enterprises IPO is among the largest healthcare public issues of 2026. With a ₹9,275.22 crore issue size, a leading hospital network, strong financial performance, and expansion strategy, the company is well positioned to benefit from India's growing healthcare demand. Investors should keep track of the GMP, subscription status, valuation, and final allotment before making an investment decision.

Frequently Asked Questions

What is the Manipal Health Enterprises IPO?

It is a Mainboard Book Build IPO worth ₹9,275.22 crore, comprising a fresh issue of ₹8,000 crore and an OFS of ₹1,275.22 crore.

What are the Manipal Health Enterprises IPO dates?

The IPO opens on 29 July 2026 and closes on 31 July 2026.

What is the Manipal Health Enterprises IPO price band?

The price band is ₹560–₹590 per equity share.

What is the lot size?

The minimum application is 25 shares, requiring an investment of ₹14,750.

What is the GMP today?

The latest Manipal Health Enterprises IPO GMP is ₹28, indicating an estimated listing price of around ₹618.

What will the IPO proceeds be used for?

The company will use the proceeds to repay borrowings, acquire a minority stake in Sahyadri Hospitals, and for general corporate purposes.

Where will the IPO be listed?

The shares will be listed on BSE and NSE.

Sources

DRHP/RHP of Manipal Health Enterprises Limited
Company filings
KFin Technologies
NSE
BSE

Disclaimer

This article is for informational purposes only and should not be considered investment advice. IPO investments are subject to market risks. Investors should read the Red Herring Prospectus (RHP), evaluate the company's financials and valuation, and consult a qualified financial advisor before making any investment decision.

Author: Komal Bhatt

Komal Bhatt is a finance content writer at InvestKraft, specialising in well-researched articles on financial products, stock markets, and investment opportunities, with a particular focus on unlisted shares.

She holds a Master’s degree in Commerce from the University of Delhi, which gives her a solid academic foundation in finance and business. With over three years of hands-on experience in creating digital finance content, Komal has developed a clear understanding of investor needs through her work on wealth management, NISM certification programs, and market education materials.

Komal is passionate when it comes to breaking down complex financial concepts into simple, accurate and actionable insights. Her goal is to help everyday investors understand markets better and make more informed decisions based on reliable, research-backed information.